The leakage of NFL and GFAP into plasma/serum is particularly useful for monitoring neuroaxonal damage in MS, and yet there are limited studies on this topic in the preclinical animal models of EAE [17,22,23,24]. The gene discussed is GFAP; the disease is myeloid sarcoma.